RRAM
TARO

River Road Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

River Road Asset Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-65,470
Closed -$7.34M – 168
2017
Q2 		$7.34M Buy
65,470
+16,350
+33% +$1.85M 0.14% 126
2017
Q1 		$5.73M Buy
+49,120
New +$5.44M 0.11% 131

Other funds holding TARO

MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

River Road Asset Management's TARO Position: Q3 2017 in Review

River Road Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 65,470 shares — an estimated $7.34M sold.

River Road Asset Management first reported a position in TARO in Q1 2017 and held it in 2 quarters. The position peaked at $7.34M in Q2 2017. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

  • River Road Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
  • River Road Asset Management sold 65,470 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $7.34M.
  • River Road Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2017 and held it in 2 quarters.
  • River Road Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $7.34M in Q2 2017.
  • 133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on River Road Asset Management's 13F filing for Q3 2017, filed 3 Nov 2017.